Diversified Biotech, Inc. – Trademark Portfolio
Entity Type: 03
Diversified Biotech, Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 20 (Furniture) — 8 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include TO-196°C, PLANETSAFE, TOUGH-TAGS, CRYO-BABIES, and TOUGH-SPOTS. The owner is based in Dedham, MA.
65 Commerce Way
Dedham, MA 02026
Showing of trademarks Trademarks
Trademark Classifications
Diversified Biotech, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Diversified Biotech, Inc. have?
Diversified Biotech, Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 6 registered, 3 abandoned, 3 cancelled.
What trademark classes does Diversified Biotech, Inc. file in?
Diversified Biotech, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 9 (Computers & Electronics), Class 16 (Paper Goods). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.
What are Diversified Biotech, Inc.'s most well-known trademarks?
Diversified Biotech, Inc.'s registered trademark portfolio includes well-known marks such as TO-196°C, PLANETSAFE, TOUGH-TAGS, CRYO-BABIES, and TOUGH-SPOTS. These are among 6 currently registered trademarks in the portfolio.
What is Diversified Biotech, Inc.'s trademark registration success rate?
Diversified Biotech, Inc. has a 50% trademark registration rate, with 6 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.